1Butterworth, B, Kovas, Y.Understanding neurocognitive developmental disorders can improve education for all. Science 2013; 340: 300–5.
3American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn). American Psychiatric Association, 2013.
4Thapar, A, Cooper, M.Attention deficit hyperactivity disorder. Lancet 2016; 387: 1240–50.
5Verkuijl, N, Perkins, M, Fazel, M.Childhood attention-deficit/hyperactivity disorder. BMJ 2015; 350: h2168.
6Thapar, A, Cooper, M, Eyre, O, Langley, K.Practitioner review: what have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013; 54: 3–16.
7Nikolas, MA, Burt, SA.Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol 2010; 119: 1–17.
8Faraone, SV, Perlis, RH, Doyle, AE, Smoller, JW, Goralnick, JJ, Holmgren, MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313–23.
9Gingerich, KJ, Turnock, P, Litfin, JK, Rosén, LA.Diversity and attention deficit hyperactivity disorder. J Clin Psychol 1998; 54: 415–26.
10Green, H, McGinnity, A, Meltzer, H, Ford, T, Goodman, R.Mental Health of Children and Young People in Great Britain, 2004: A Survey Carried Out by the Office for National Statistics on Behalf of the Department of Health and the Scottish Executive. HMSO, 2005.
11Rutter, M, Beckett, C, Castle, J, Colvert, E, Kreppner, J, Mehta, M, et al. Effects of profound early institutional deprivation: an overview of findings from a UK longitudinal study of Romanian adoptees. Eur J Dev Psychol 2007; 4: 332–50.
12Hjern, A, Weitoft, GR, Lindblad, F.Social adversity predicts ADHD-medication in school children - a national cohort study. Acta Paediatr 2009; 99: 920–4.
13Bahmanyar, S, Sundström, A, Kaijser, M, Von Knorring, A-L, Kieler, H.Pharmacological treatment and demographic characteristics of pediatric patients with attention deficit hyperactivity disorder, Sweden. Eur Neuropsychopharmacol 2013; 23: 1732–8.
14Miller, AR, Kohen, D, Johnston, C.Child characteristics and receipt of stimulant medications: a population-based study. Ambul Pediatr 2008; 8: 175–81.
15Chen, C-Y, Gerhard, T, Winterstein, AG.Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009; 19: 187–95.
17Department for Communities and Local Government. The English Index of Multiple Deprivation (IMD) 2015 – Guidance. Department for Communities and Local Government, 2015.
19Wallach-Kildemoes, H, Skovgaard, AM, Thielen, K, Pottegård, A, Mortensen, LH.Social adversity and regional differences in prescribing of ADHD medication for school-age children. J Dev Behav Pediatr 2015; 36: 330–41.
20Choi, Y, Shin, J, Cho, KH, Park, E-C.Change in household income and risk for attention deficit hyperactivity disorder during childhood: a nationwide population-based cohort study. J Epidemiol 2017; 27: 56–62.
21Russell, G, Ford, T, Rosenberg, R, Kelly, S.The association of attention deficit hyperactivity disorder with socioeconomic disadvantage: alternative explanations and evidence. J Child Psychol Psychiatry 2014; 55: 436–45.
22Koerting, J, Smith, E, Knowles, MM, Latter, S, Elsey, H, McCann, DC, et al. Barriers to, and facilitators of, parenting programmes for childhood behaviour problems: a qualitative synthesis of studies of parents’ and professionals’ perceptions. Eur Child Adolesc Psychiatry 2013; 22: 653–70.
23Leitner, Y.The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know? Front Hum Neurosci 2014; 8: 268.
24National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE, 2018, last updated 2019 (https://www.nice.org.uk/guidance/ng87).